Tabby Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Tabby Therapeutics General Information
Description
Developer of therapeutic drugs based in Ness Ziona, Israel. The company focuses on the broader applications of B-cell technology in therapeutics and drug discovery, enabling healthcare professionals to treat diseases.
Contact Information
Corporate Office
- Peleg 8
- Ness Ziona 7420848
- Israel
Corporate Office
- Peleg 8
- Ness Ziona 7420848
- Israel
Tabby Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2021 | Completed | Startup |
Tabby Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ramot at Tel Aviv University | University | Minority | ||
| Arkin Capital | Asset Manager | Minority |
Tabby Therapeutics FAQs
-
When was Tabby Therapeutics founded?
Tabby Therapeutics was founded in 2021.
-
Where is Tabby Therapeutics headquartered?
Tabby Therapeutics is headquartered in Ness Ziona, Israel.
-
What industry is Tabby Therapeutics in?
Tabby Therapeutics’s primary industry is Drug Discovery.
-
Is Tabby Therapeutics a private or public company?
Tabby Therapeutics is a Private company.
-
What is Tabby Therapeutics’s current revenue?
The current revenue for Tabby Therapeutics is .
-
Who are Tabby Therapeutics’s investors?
Ramot at Tel Aviv University and Arkin Capital have invested in Tabby Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
